B&L to join with German-based refractive surgery business
Alcon repurchases one million shares
Gazing at targets while driving improves stability, study finds
Acucela Inc. and Otsuka Pharmaceutical Co. Ltd. have entered into agreements to co-develop Otsuka?s proprietary compound for the treatment of dry eye.
Allergan Inc. has launched a new national dry eye campaign with the Red Hot Mamas, a menopause education provider.
Schwind eye-tech-solutions and Ziemer Ophthalmic solutions have formed a marketing alliance to offer an integrated system featuring their lasers for refractive surgeons performing all-laser LASIK.
Othera Pharmaceuticals Inc. has begun dosing in a phase I/II multicenter, investigator-masked clinical trial of the safety and efficacy of a topical drug (OT-730) in reducing IOP in subjects with ocular hypertension or open-angle glaucoma
Merck & Co. Inc. will pay SurModics Inc. $9 million after deciding to end the license and research collaboration agreement the companies signed in June 2007, according to SurModics.
Alcon Inc. broke ground on an expansion of its medical device manufacturing facility in Huntington, WV, Sept. 19.
